2026-10-09T22:16:50Z https://api.figshare.com/v2/oai

oai:figshare.com:article/34026733 2026-09-29T17:37:31Z category_7 category_13 category_19 category_46 category_64 category_122 portal_5 item_type_6 month_year_09_2026

<p>Complete clinical outcomes: All 20 prespecified endpoints, with event counts.</p> Po-Huang Chen (8374326) Ming-Shen Dai (835570) Mao-Hsuan Huang (17475456) Hsin-Yu Chen (2165956) Li-Ting Kao (409065) Tina Yi-Jin Hsieh (22887737) Hong-Jie Jhou (9376258) Cho-Hao Lee (4114723) Medicine Genetics Pharmacology Immunology Cancer Mental Health showed null associations related adverse events propensity score matching prior 365 days preceding 90 days level pattern matched groups may differ everyday functional ability enhancing antitumor immunity cd8 +&# 8201 cancer genome atlas 20 cancer types first ici administration 008 ), driven cannot localize slc6a4 272 tumor samples year overall survival target trial emulation bzd prescription overlapping >- value 2 134 matched patients slc6a4 expression related immune checkpoint blockade users among patients hr range 0 target trial slc6a4 expression immune checkpoint tumor immune ssri users among 3 solid tumor composite immune xlink "> versus 34 thyroid dysfunction starting within ssri use ssri repurposing ssri group solid tumors serotonin transporter residual confounding psychiatric comorbidity primary outcome performance status <p>Complete clinical outcomes: All 20 prespecified endpoints, with event counts.</p> 2026-09-29T18:01:32Z Text Journal contribution 10.1371/journal.pmed.1005262.s015 https://figshare.com/articles/journal_contribution/_p_Complete_clinical_outcomes_All_20_prespecified_endpoints_with_event_counts_p_/34026733 CC BY 4.0